Achieving appropriate model transparency: challenges and potential solutions for making value‑based decisions in the United States

PharmacoEconomics

5 September 2019 - Transparency in decision modeling remains a topic of rigorous debate among healthcare stakeholders, given tensions between the potential benefits of external access during model development and the need to protect intellectual property and reward research investments. 

Strategies to increase decision model transparency by allowing direct external access to a model’s structure, source code, and data can take on many forms but are bounded between the status quo and free publicly available open-source models. Importantly, some level of transparency already exists in terms of methods and other technical specifications for published models. 

The purpose of this paper is to delineate pertinent issues surround-ing efforts to increase transparency via direct access to models and to offer key considerations for the field of health economics and outcomes research moving forward from a US academic perspective.

Read PharmacoEconomics article

Michael Wonder

Posted by:

Michael Wonder